Title: Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.
Journal: Bioorganic & medicinal chemistry letters 20101101
160600-35-1
302551-41-3
307548-90-9
843621-27-2
314742-28-4
314743-72-1
421-06-7 | 2-Bromo-1,1,1-trifluoroethane | AA0073KI | MFCD00000442
40887-05-6 | Hydrazinecarboxylicacid, 2-phenyl-, phenylmethyl ester | AA00740K | MFCD00087301
185040-34-0 | (4-(Ethylamino)-2-(methylthio)pyrimidin-5-yl)methanol | AA0074K0 | MFCD12911521
120788-07-0 | 4-Thia-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylicacid,6-[(1R)-1-hydroxyethyl]-7-oxo-3-[[(1R,3S)-tetrahydro-1-oxido-3-thienyl]thio]-,(5R,6S)- | AA007540 | MFCD00865089
186320-14-9 | Fmoc-4-(4-aminophenyl)butanoic acid | AA0075LZ | MFCD04974543
39149-82-1 | Ethyl 2-bromo-3-phenylpropanoate | AA00763A | MFCD01910053
390811-95-7 | 1-Cyclohexyl-2-(3-furanyl)-1h-benzimidazole-5-carboxylic acid | AA0076I2 | MFCD09743847
389621-77-6 | 4-(2-Aminoethyl)tetrahydropyran, HCl | AA00770K | MFCD03411927
369403-08-7 | 1-((tert-Butoxycarbonyl)amino)-4-hydroxycyclohexanecarboxylic acid | AA0077JG | MFCD02683153
1189678-81-6 | Salicylic Acid-13C6 | AA0077XI | MFCD20257120
620560-52-3
Journal: Bioorganic & medicinal chemistry letters20101101